Mental Health News and Research

Latest Mental Health News and Research

Parkinson's Disease Foundation awards $1.2M for research programs

The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling $1.2 million for research projects designed to understand the cause(s) of and find a cure for Parkinson's disease (PD).

2 Jul 2010

Federal officials ask judge to order upgrade of Georgia's mental health system; VA. officials in court today on suit against health law

Atlanta Journal Constitution: "Talks to settle a federal investigation of Georgia's mental health system came down to a single meeting Wednesday." And, "the talks failed. Federal authorities immediately went to court, asking a judge to force Georgia to make substantial and potentially expensive improvements in its state psychiatric hospitals and in its community-based treatment services — the same measures state officials rejected during the negotiations.

2 Jul 2010

Elements Behavioral Health acquires The Ranch in Tennessee

Elements Behavioral Health, provider of residential treatment services for addiction and co-occurring disorders, announced this week the acquisition of The Ranch in Nunnelly, Tennessee. Elements is best known to the public as the owner of the internationally famous Promises Treatment Centers in Malibu and Los Angeles, where many Hollywood celebrities have been treated successfully for substance abuse.

2 Jul 2010

Imbalance in neuroendocrine system linked to depression in MS patients: Study

Now, in the first such study in living humans, researchers at UCLA suggest a cause, and it's not psychological, but physical: atrophy of a specific region of the hippocampus, a critical part of the brain involved in mood and memory, among other functions.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..

1 Jul 2010

Aptuit to acquire GSK's research business in Verona

GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.

1 Jul 2010

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Some of the first analyses on the impact of Medicare Part D, as well as new insights on drug adherence patterns by chronic disease patients, will be presented today and tomorrow at the 2010 Academy/Health Annual Meeting by several University of Maryland, Baltimore teams of pharmaceutical health services researchers.

1 Jul 2010

Study examines long-term effect of TBI on women's reproductive health

After a brain injury, women often ask how the injury will affect their fertility, pregnancy and postpartum health. Now a new study provides some much-needed answers. Published in the June issue of the Journal of Women's Health, the study is the most comprehensive investigation to date of women's health issues after traumatic brain injury.

1 Jul 2010

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

Evotec AG today announced the start of the proof-of-concept Phase II study in treatment-resistant depression with its NR2B subtype selective NMDA receptor antagonist EVT 101. This clinical development is part of an alliance between Evotec and Roche.

1 Jul 2010

Research findings open new ways to enhance memory function and treat catastrophic brain diseases

For the first time, scientists have linked a brain compound called kynurenic acid to cognition, possibly opening doors for new ways to enhance memory function and treat catastrophic brain diseases, according to a new study from the University of Maryland School of Medicine. When researchers decreased the levels of kynurenic acid in the brains of mice, their cognition was shown to improve markedly, according to the study, which was published in the July issue of the journal Neuropsychopharmacology.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Neuralstem announces completion of $10 million registered direct offering

Neuralstem, Inc. (NYSE Amex: CUR) announced that it has completed its previously announced registered direct offering of $10 million of units to institutional investors. The units were priced at $2.80 and consisted of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years. Net proceeds from this offering, after deducting placement agent fees and other offering expenses, total approximately $9.2 million. All of the securities were offered pursuant to an effective shelf registration statement.

1 Jul 2010

Focus shifts to mental health policies

According to Health Minister Nicola Roxon, the Coalition has gone “crazy” for providing funds to promote its mental health policy by closing down the Labour health reforms in general practice and record keeping.

1 Jul 2010

Blue Shield of California offers SilverSneakers Fitness Program to Medicare Supplement Plan subscribers

Blue Shield of California is now offering the Healthways SilverSneakers® Fitness Program to subscribers of Blue Shield Medicare Supplement Plans throughout California. SilverSneakers, the nation's leading social support and exercise program designed to keep seniors healthy, has been a popular benefit with California Medicare HMOs, but Blue Shield is one of the few health plans in the state to offer the benefit as part of its Medicare Supplement plans as well.

30 Jun 2010

Health law provisions kicking in; States prepare for high-risk insurance pool implementation

Three months after health reform was enacted, state leaders are beginning to make decisions about implementing the new law, Politico reports: "With the messy politics of health reform, the burden of balancing state budgets and the goal of expanding health coverage, lawmakers at the state level have had mixed reactions."

30 Jun 2010

Qigong and Tai Chi offer physical and mental health benefits

An across-the-board review of the health effects of Qigong and Tai Chi finds these practices offer many physical and mental health advantages with benefits for the heart, immune system and overall quality of life.

30 Jun 2010

States struggle as Congress fails to come through with extra Medicaid money

Congress' rejection - at least for now - of a package extending $16 billion in Medicaid funding and $35.5 billion in other jobless benefits has left at least 30 states struggling to balance next fiscal year's budgets with tax increases, spending cuts and layoffs, The Associated Press reports. The new fiscal year begins in just days for most states.

30 Jun 2010

New hope for patients with drug-resistant depression

New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.

30 Jun 2010

FDA grants approval for first generic version of Effexor XR antidepressant capsules

On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.

30 Jun 2010

Mental Health News and Research

Latest Mental Health News and Research

Parkinson's Disease Foundation awards $1.2M for research programs

Federal officials ask judge to order upgrade of Georgia's mental health system; VA. officials in court today on suit against health law

Elements Behavioral Health acquires The Ranch in Tennessee

Imbalance in neuroendocrine system linked to depression in MS patients: Study

Does too much texting puts teenagers at risk?

Hospira subsidiary completes tender offer for Javelin's outstanding shares of common stock

Aptuit to acquire GSK's research business in Verona

First analyses on impact of Medicare Part D presented at UMB's 2010 Academy/Health Annual Meeting

Study examines long-term effect of TBI on women's reproductive health

Evotec commences EVT 101 proof-of-concept Phase II study in treatment-resistant depression

Research findings open new ways to enhance memory function and treat catastrophic brain diseases

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Neuralstem announces completion of $10 million registered direct offering

Focus shifts to mental health policies

Blue Shield of California offers SilverSneakers Fitness Program to Medicare Supplement Plan subscribers

Health law provisions kicking in; States prepare for high-risk insurance pool implementation

Qigong and Tai Chi offer physical and mental health benefits

States struggle as Congress fails to come through with extra Medicaid money

New hope for patients with drug-resistant depression

FDA grants approval for first generic version of Effexor XR antidepressant capsules

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Mental Health News and Research

Latest Mental Health News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in